Watchlist Price Alert

Karyopharm Therapeutics I... (KPTI)

NASDAQ: KPTI · Real-Time Price · USD

6.12

-0.15 (-2.39%)

At close: May 07, 2025, 3:59 PM

6.11

-0.16%

After-hours: May 07, 2025, 04:05 PM EDT

Karyopharm Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	62.48M	52.23M	135.19M	190.46M	85.92M	128.86M	118.02M	69M	49.66M
Short-Term Investments	46.24M	139.21M	142.78M	38.16M	163.32M	133.1M	210.18M	77.47M	79.89M
Long-Term Investments	n/a	n/a	633K	637K	24.21M	2.02M	2M	29.4M	45.43M
Other Long-Term Assets	1.64M	1.64M	23.41M	44.93M	-2.92M	16.24M	716K	290K	479K
Receivables	30.77M	26.96M	47.09M	22.5M	12.88M	7.86M	n/a	n/a	n/a
Inventory	4.74M	3.04M	4.22M	4.11M	2.64M	346K	n/a	n/a	n/a
Other Current Assets	12.28M	12.47M	20.89M	6.35M	2.48M	1.12M	6.41M	1.95M	2.08M
Total Current Assets	156.49M	233.92M	326.75M	258.1M	289.54M	273.67M	334.61M	148.42M	131.64M
Property-Plant & Equipment	6.28M	4.88M	7.38M	1.64M	2.22M	3.05M	3.86M	2.19M	2.84M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.93M	6.52M	31.42M	47.21M	23.51M	21.3M	6.58M	31.87M	48.75M
Total Assets	164.42M	240.44M	358.17M	305.31M	313.05M	294.96M	341.19M	180.29M	180.38M
Account Payables	5.11M	3.12M	2.77M	1.6M	4.45M	985K	4.33M	5.67M	4.75M
Deferred Revenue	n/a	n/a	n/a	69.12M	297K	2.34M	9.36M	21.92M	280K
Short-Term Debt	24.43M	n/a	2.87M	2.32M	1.92M	1.65M	n/a	n/a	n/a
Other Current Liabilities	62.29M	46.54M	37.77M	47.8M	35.41M	26.1M	23.11M	17.9M	8.25M
Total Current Liabilities	92.26M	69.48M	65.91M	73.72M	297K	46.35M	46.9M	49.47M	16.48M
Long-Term Debt	162.95M	170.92M	170.1M	169.29M	117.93M	109.86M	102.66M	n/a	n/a
Other Long-Term Liabilities	95.22M	133.46M	132.72M	133M	73.09M	n/a	3.92M	1.36M	1.67M
Total Long-Term Liabilities	258.17M	307.17M	374.83M	384.98M	262.21M	245.19M	111.12M	1.36M	1.67M
Total Liabilities	350.44M	376.64M	374.83M	384.98M	262.5M	245.19M	158.02M	50.83M	18.14M
Total Debt	194.52M	177.02M	172.98M	169.29M	117.93M	109.86M	102.66M	n/a	n/a
Common Stock	13K	12K	12K	8K	7K	7K	6K	5K	4K
Retained Earnings	-1.56B	-1.49B	-1.34B	-1.18B	-1.07B	-873.34M	-673.75M	-495.34M	-366.1M
Comprehensive Income	-356K	-161K	-638K	191K	518K	-37K	-244K	-217K	-274K
Shareholders Equity	-186.02M	-136.21M	-16.66M	-79.67M	50.55M	49.77M	183.17M	129.46M	162.24M
Total Investments	46.24M	139.21M	142.78M	38.16M	187.54M	135.11M	212.18M	106.87M	125.32M